DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
Brain; 133 (3): 713-726. doi: 10.1093/brain/awq008.
Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein
Proteomics. 2010 Jun;10(11):2138-50. doi: 10.1002/pmic.200900745.
Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1
J Immunol. 2010 Jul 1;185(1):615-23. doi: 10.4049/jimmunol.0903480
Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations
Clin Exp Immunol. 2010 Sep;161(3):527-35. doi: 10.1111/j.1365-2249.2010.04214.x
Production of a monoclonal antibody, against human α-synuclein, in a subpopulation of C57BL/6J mice, presenting a deletion of the α-synuclein locus.
J Neurosci Methods. 2010 Oct 15;192(2):268-76. doi: 10.1016/j.jneumeth.2010.08.010.
On-line bioaffinity-electrospray mass spectrometry for simultaneous detection, identification, and quantification of protein-ligand interactions
J Am Soc Mass Spectrom. 2010 Oct;21(10):1643-8. doi: 10.1016/j.jasms.2010.06.011
SNCA variant associated with Parkinson disease and plasma alpha-synuclein level
Arch Neurol. 2010 Nov;67(11):1350-6. doi: 10.1001/archneurol.2010.279.